3.75 (0.36%) In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time (the ‘Listing Regulations’) read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 (‘SEBI Circular’), Max Healthcare Institute has informed that on February 11, 2022, the Company has entered into a Share Purchase Agreement (SPA) and a Shareholders’ Agreement (SHA) and other definitive agreements for acquisition of equity stake in Eqova Healthcare (Eqova) in a phased manner.
The above information is a part of company’s filings submitted to BSE.